Psychological, Neurological and Immunological Changes Following a Meeting With a Chaplain Coupled With Biblical Readings (HEALING)

October 11, 2019 updated by: Dr. András Béres, Somogy Megyei Kaposi Mór Teaching Hospital

Hospital-based Ecumenical And Linguistical, Immuno- Neuro-Genetic (HEALING) Study - Randomized Clinical Trial - A Study on the Epigenetic Background of Neuro-immune-modulation in Clinical Environment

The aim of the "HEALING" " (Hospital-based Ecumenical And Linguistic Immuno-NeuroloGic) Study was to examine immunological and neurological changes in hospitalized participants after meeting a chaplain and Biblical listenings, in order to evaluate whether these meetings affect the course of the disease.

Study Overview

Status

Completed

Conditions

Detailed Description

The authors pre-screened hospitalized participants to find those who were the most in need of an intervention by a chaplain. A passage from the Bible was read to the participants during a meeting with the chaplain at the bedside, or in the chapel of the hospital. No meeting occurred in the randomized control group, which was compiled in a way to get a group of participants with an approximatively similar pattern of diagnoses and treatment days than the intervention groups. The pace of enrollment was deliberately slow in order to assure the authenticity of the visits ("slow science"). Blood samples were taken 30 minutes prior, and 60 minutes after the meeting to measure White Blood Cell (WBC)-, lymphocyte counts, interferon gamma (IFN-γ)-, immunoglobulin M (IgM)-, immunoglobulin A (IgA)-, immunoglobulin G (IgG)-, and complement C3 levels. A subgroup of the visited participants was subjected to functional Magnetic Resonance Imaging (fMRI), where they were played an audiotape of readings of the same passage from the Bible. Associative tests, paired-samples t-test, network analysis was performed to search for any correlation between psychological and immunological parameters, completed with Statistical Parametric Mapping to search for correlations of the above with neurological parameters.

Study Type

Interventional

Enrollment (Actual)

57

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kaposvár, Hungary, 7400
        • Somogy Megyei Kaposi Mór Teaching Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adult age (>18 years)
  • the condition of being hospitalized
  • the ability for verbal communication
  • alertness, orientation
  • no sign of psychosis in their medical history
  • willingness to participate in the study after written, informed consent

Exclusion Criteria:

  • the inability to communicate verbally
  • psychotic state, altered mental state
  • unwillingness to participate
  • active and treated malignant disease
  • steroid, NSAID or metamizole- sodium use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients Meeting the Chaplain at the Bedside
First meeting with the chaplain, coupled with biblical readings at the bedside.
Experimental: Patients Meeting the Chaplain at the Chapel
First meeting with the chaplain, coupled with biblical readings at the hospital's chapel
No Intervention: Patients Not Meeting the Chaplain
In the control group we enrolled patients whose diagnoses and number of days in the hospital was similar to the intervention groups (covariate-adaptive, blocked, stratified randomization method).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in lymphocyte count
Time Frame: Change from baseline at 120 minutes
lymphocyte count measured with automatised laboratory measurement and microscopic blood smear examination
Change from baseline at 120 minutes
Change in total white blood cell (WBC) count
Time Frame: Change from baseline at 120 minutes
WBC count measured with automatised laboratory measurement and microscopic blood smear examination
Change from baseline at 120 minutes
Change in interferon-gamma level
Time Frame: Change from baseline at 120 minutes
enzyme-linked immunosorbent assay
Change from baseline at 120 minutes
Change in immunoglobulin M level
Time Frame: Change from baseline at 120 minutes
enzyme-linked immunosorbent assay
Change from baseline at 120 minutes
Change in immunoglobulin A level
Time Frame: Change from baseline at 120 minutes
enzyme-linked immunosorbent assay
Change from baseline at 120 minutes
Change in immunoglobulin G level
Time Frame: Change from baseline at 120 minutes
enzyme-linked immunosorbent assay
Change from baseline at 120 minutes
Change in complement C3 level
Time Frame: Change from baseline at 120 minutes
enzyme-linked immunosorbent assay
Change from baseline at 120 minutes
Change in functional Magnetic Resonance Imaging activity
Time Frame: Change from baseline during the 60 second long activation block
Statistical Parametric Mapping analysis of Blood Oxygenation Level Dependent (BOLD) answers
Change from baseline during the 60 second long activation block
Participants' satisfaction with the visit as assessed by Scores given on the "Healing - after" Questionnaire
Time Frame: within 1 hour after intervention
Participants' assessement of their satisfaction on single-item rating scales in a Questionnaire designed for the Study. Answers range from 1 to 5, with higher values representing better outcomes.
within 1 hour after intervention
Chaplain's satisfaction with the visit as assessed by Scores given on the "Healing - after" Questionnaire
Time Frame: within 1 hour after intervention
Chaplain's assessement of her satisfaction on single-item rating scales in a Questionnaire designed for the Study. Answers range from 1 to 5, with higher values representing better outcomes.
within 1 hour after intervention
Participants' level of distress in the month preceding the measurement as assessed with the total Score of the Perceived Stress Scale 14 (PSS-14)
Time Frame: within 30 minutes before intervention
PSS-14 Scale uses 14 questions with answers ranging from 0 to 4, with higher values indicating higher levels of distress on the seven negative-, and lower levels of distress on the seven positive items. Scores are obtained by reversing the scores on the seven positive items, then summing across all to give the total PSS-14 Score.
within 30 minutes before intervention
Participants' spiritual and psychological needs, religious practice, thoughts about how they became sick, and how they could heal, as assessed by Scores given on the "Healing - before" Questionnaire
Time Frame: within 30 minutes before intervention
Participants' assessement on single-item rating scales in a Questionnaire designed for the Study ("Healing - before" Questionnaire). Answers range from 1 to 5, with higher values representing better outcomes.
within 30 minutes before intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: András Béres, M.D., Physician

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2015

Primary Completion (Actual)

January 2, 2017

Study Completion (Actual)

January 2, 2017

Study Registration Dates

First Submitted

September 29, 2019

First Submitted That Met QC Criteria

September 30, 2019

First Posted (Actual)

October 2, 2019

Study Record Updates

Last Update Posted (Actual)

October 15, 2019

Last Update Submitted That Met QC Criteria

October 11, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • HEALING STUDY IG/3355/2013

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hospitalism

Clinical Trials on Meeting with a Chaplain coupled with Biblical Readings

Subscribe